Kavita Aggarwal
Chief Tech/Sci/R&D Officer at VERONA PHARMA PLC
Profile
Kavita Aggarwal is a professional with a current job as Senior Vice President-Medical Affairs at Verona Pharma Plc since 2023.
Prior to this, she worked as VP-Global Commercial Pipeline Strategy at BioCryst Pharmaceuticals, Inc. and as Vice President-Medical Affairs at Dova Pharmaceuticals, Inc. Dr. Aggarwal completed her undergraduate degree at North Carolina State University and her doctorate at the University of North Carolina at Chapel Hill.
Kavita Aggarwal active positions
| Companies | Position | Start |
|---|---|---|
| VERONA PHARMA PLC | Chief Tech/Sci/R&D Officer | 2022-12-31 |
Former positions of Kavita Aggarwal
| Companies | Position | End |
|---|---|---|
| DOVA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Kavita Aggarwal
| North Carolina State University | Undergraduate Degree |
| University of North Carolina at Chapel Hill | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| VERONA PHARMA PLC | Health Technology |
| Private companies | 1 |
|---|---|
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Kavita Aggarwal
